EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte Studie

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey

Hilary Baldwin, Julie C Harper, Joshua A Zeichner, Zoe D Draelos, Lawrence F Eichenfield, Michael Gold, Linda Stein Gold, Leon H Kircik

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.8639 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Hilary Baldwin und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Administration, Cutaneous, Benzoyl Peroxide, Dermatologic Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisAdministration, CutaneousBenzoyl PeroxideDermatologic AgentsDrug CombinationsGelsSeverity of Illness IndexAdolescentAdultChildFemaleHumansMaleYoung AdultDouble-Blind MethodTreatment OutcomeClindamycin

Substanzen

Benzoyl PeroxideDermatologic AgentsDrug CombinationsGelsclindamycin phosphateClindamycin

Zitieren

APA

Baldwin, H., Harper, J. C., Zeichner, J. A., Draelos, Z. D., Eichenfield, L. F., Gold, M., Gold, L. S., & Kircik, L. H. (2024). Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8639

Vancouver

Baldwin H, Harper JC, Zeichner JA, Draelos ZD, Eichenfield LF, Gold M, et al. Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.8639

BibTeX
@article{Baldwin2024,
  author = {Baldwin, Hilary and Harper, Julie C and Zeichner, Joshua A and Draelos, Zoe D and Eichenfield, Lawrence F and Gold, Michael and Gold, Linda Stein and Kircik, Leon H},
  title = {Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.8639}
}
Kostenlos starten →